Remove 2013 Remove Access Remove Patients
article thumbnail

The Latin American Cannabis Landscape – Part Two: Regulated Markets and Patient Access

CannaTech

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.

Access 89
article thumbnail

Rep. Lee: I Just Introduced The Marijuana Justice Act

NORML

Although whites and blacks have been found to use marijuana at similar rates, a 2013 report by the ACLU found that a “black person is 3.73 Members of Congress must not turn their backs on the millions of Americans nationwide who rely on access to marijuana for their health, wellness, and liberty.

Marijuana 267
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NORML Activist Spotlight: Tamara Netzel

NORML

She was diagnosed with Multiple Sclerosis in 2013, and for a few years believed she could continue to teach and live her life as long as she followed all the doctors recommendations and took the medications they prescribed. It concerned her that even as a registered patient, she could still be arrested.

Advocacy 318
article thumbnail

Why the MRTA gets an A- & the CRTA gets a C-

NORML

The MRTA ( Marijuana Regulation and Taxation Act ) was first introduced by Assembly Majority Leader Crystal Peoples-Stokes and Senator Liz Krueger in 2013, and has been re-introduced every session since. Medical patients are restricted to 4 plants total, per household. Access to commonly found cannabis products in the regulated market.

Programs 214
article thumbnail

Canada Opens Access for Psilocybin and MDMA Therapy

Cannabis Law Report

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. 01.015 of the FDR before providing the new drug to a patient. Timeline of Medicinal Legalization in Canada. Pursuant to subsection C.08.010(1)

Therapy 52
article thumbnail

Khiron Welcomes Dr. Eduardo Faveret as Medical Director for Brazil

Cannabis Law Report

In 2013, Dr. Faveret became one of the first physicians in Brazil to prescribe medical cannabis extract to a child, subsequently treating more than 3,000 patients with conditions such as Alzheimer’s, Parkinson’s, MS, cancer, anxiety, depression, insomnia, Tourette’s syndrome, autism, and chronic pain, among others.

article thumbnail

Medical Cannabis Growers Have Privacy Rights: Federal Court

Cannabis Life Network

Once upon a time, the government regulated medical cannabis through the Marihuana Medical Access Regulations (MMAR). Under the MMAR, patients could grow their own cannabis plants or have someone designated to do it for them.

Access 82